PURPOSE To provide evidence-based recommendations to practicing clinicians on
management of patients with stage III non–small-cell lung cancer (NSCLC). METHODS An …

PURPOSE To provide evidence-based recommendations for practicing physicians and
other healthcare providers on the management of salivary gland malignancy. METHODS …

In numerous types of cancer, the primary tumor site can show a correlation with disease
behavior and survival outcomes. In salivary gland tumors (SGTs) this association remains …

Purpose Salivary gland carcinoma is a rare disease and studies on epidemiology and
outcome require data collection over many years. The aim of this study is to present an …

Simple Summary Clinical management of Malignant Salivary Gland Tumors is still a
challenge for clinicians. Direct and indirect costs for the diagnosis and treatment of these …

Introduction To investigate whether the positive lymph node number (PLNN) and positive
lymph node ratio (PLNR) could predict the prognosis of patients with major salivary gland …

Background High-grade salivary gland cancer is a distinct clinical entity that has aggressive
disease progression and early systemic spread. However, because of the rarity of the …

Purpose Salivary gland carcinomas (SGC) are rare malignancies and data regarding
treatment outcomes stratified by histologic subtype are currently limited. This study aims to …

Background Histologic grade of tumor is one of the major prognostic predictors for patients
with salivary gland cancer. Because of disease rarity, little is known about the optimal …

Background Proton beam radiation therapy (PBRT) has dosimetric advantages compared to
photon radiation therapy for the treatment of major salivary gland tumors (MSGTs). Methods …